Aspirin Dosing for Acute Pericarditis
For acute pericarditis in adults, administer aspirin 750-1000 mg orally every 8 hours (2250-3000 mg total daily dose) for 1-2 weeks, with mandatory gastroprotection and colchicine as adjunctive therapy. 1
Dosing Algorithm
Initial Treatment Phase
- Aspirin dose: 750-1000 mg every 8 hours (three times daily)
- Duration: 1-2 weeks for uncomplicated cases
- Gastroprotection: Mandatory proton pump inhibitor or H2-blocker
- Colchicine co-administration: Required as first-line adjunct therapy
- 0.5 mg once daily if <70 kg
- 0.5 mg twice daily if ≥70 kg
- Continue for 3 months 1
Treatment Duration Guidance
The 1-2 week duration is symptoms and CRP-guided, not arbitrary. Continue the initial dose until:
- Complete symptom resolution
- Normalization of C-reactive protein (CRP)
- Then begin tapering 1
Tapering Protocol
Once symptoms resolve and CRP normalizes:
- Decrease by 250-500 mg every 1-2 weeks
- Monitor for symptom recurrence during taper
- If symptoms return, resume previous effective dose 1
Critical Implementation Points
Why This Specific Dose Matters
The 2015 ESC Guidelines provide Class I, Level A recommendations for aspirin/NSAIDs as first-line therapy 1. This is the highest level of evidence-based recommendation. The specific dose range of 750-1000 mg every 8 hours represents anti-inflammatory dosing (not antiplatelet dosing), which is essential for controlling pericardial inflammation.
Common Pitfalls to Avoid
Inadequate dosing: Using low-dose aspirin (81-325 mg daily) is insufficient—this is antiplatelet dosing, not anti-inflammatory dosing. The therapeutic dose is 2250-3000 mg daily divided into three doses.
Premature tapering: Starting to taper before CRP normalizes is a major cause of recurrence. Up to 30% of patients experience recurrence after initial episodes, increasing to 50% with inadequate initial treatment 1.
Omitting colchicine: Colchicine is not optional—it carries a Class I, Level A recommendation as adjunctive therapy and significantly reduces recurrence risk 1.
Using corticosteroids first-line: Corticosteroids are Class III (not recommended) for first-line therapy because they promote chronicity and drug dependence 1.
Forgetting gastroprotection: High-dose aspirin without gastroprotection significantly increases bleeding risk, particularly in patients >60 years or with prior ulcer history.
When to Choose Aspirin vs. Other NSAIDs
Select aspirin over ibuprofen (600 mg every 8 hours) when:
- Patient already requires antiplatelet therapy for coronary disease
- Patient has history of good response to aspirin
- No contraindications exist 1
Both are equally effective for pericarditis, but aspirin may be preferred in post-MI pericarditis (Dressler syndrome) where antiplatelet therapy is already indicated 2.
Monitoring Requirements
- CRP levels: Essential for guiding treatment duration and tapering decisions (Class IIa recommendation) 1
- Symptom assessment: Daily during acute phase
- Response evaluation: Should see improvement within 7 days; failure to respond is a poor prognostic indicator requiring hospital admission and etiology search 1
Activity Restriction
- Non-athletes: Restrict physical activity beyond ordinary sedentary life until symptom resolution, CRP normalization, and normal ECG/echocardiogram
- Athletes: Minimum 3-month restriction from competitive sports after symptom onset 1
Alternative Therapy Indications
Reserve corticosteroids (prednisone 0.2-0.5 mg/kg/day) only for:
- Contraindication to aspirin/NSAIDs
- Failure of aspirin/NSAIDs and colchicine
- Specific autoimmune disease indication
- After excluding infectious causes 1
This evidence-based approach from the 2015 ESC Guidelines represents the current standard of care and has been validated in multiple subsequent studies 3, 4, 5.